Work

Transferable Immunoglobulin A–Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation

Year: 2021

Type: article

Source: Gastroenterology

DOI: 10.1053/j.gastro.2021.09.061

Authors: Svetlana F. Lima, Lasha Gogokhia, Monica Viladomiu, Lance Chou, Gregory Putzel, Wen-Bing Jin, Silvia Pires, Chun-Jun Guo, Ylaine Gerardin, Carl V. Crawford, Vinita Jacob, Ellen Scherl, Su-Ellen Brown, John Hambor, Randy S. Longman

Institutions: NewYork–Presbyterian Hospital, Weill Cornell Medicine, Weill Cornell Medical Center, St Mary's Hospital, Finch Therapeutics (United States), Boehringer Ingelheim (United States)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Boehringer Ingelheim, Boehringer Ingelheim, Kenneth Rainin Foundation, Crohn's and Colitis Foundation, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1252553166, A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL), Host-Microbiota Interactions in Crohn's Disease-associated Spondyloarthritis, G7554579217, TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis

OpenAlex ID: W3202490198

FWCI: 14.31

Cites: 46

Cited by: 171

Related to: 10